Table of Contents
Molecular Biology International
Volume 2011, Article ID 571242, 23 pages
http://dx.doi.org/10.4061/2011/571242
Review Article

Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions

1Division of Infectious Diseases and Immunology, Indian Institute of Chemical Biology, Council of Scientific and Industrial Research, 4 Raja S. C. Mullick Road, Kolkata West Bengal 700032, India
2Division of Cell Biology and Immunology, Institute of Microbial Technology, Council of Scientific and Industrial Research, Chandigarh 160036, India

Received 18 January 2011; Accepted 5 March 2011

Academic Editor: Hemanta K. Majumder

Copyright © 2011 Arun Kumar Haldar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [131 citations]

The following is the list of published articles that have cited the current article.

  • Manu Vanaerschot, Saskia Decuypere, Tim Downing, Hideo Imamura, Olivia Stark, Simonne De Doncker, Syamal Roy, Bart Ostyn, Louis Maes, Basudha Khanal, Marleen Boelaert, Gabriele Schoenian, Matthew Berriman, Francois Chappuis, Jean-Claude Dujardin, Shyam Sundar, and Suman Rijal, “Genetic Markers for SSG Resistance in Leishmania donovani and SSG Treatment Failure in Visceral Leishmaniasis Patients of the Indian Subcontinent,” Journal Of Infectious Diseases, vol. 206, no. 5, pp. 752–755, 2012. View at Publisher · View at Google Scholar
  • Dawn M. Wetzel, Diane McMahon-Pratt, and Anthony J. Koleske, “The Abl and Arg Kinases Mediate Distinct Modes of Phagocytosis and Are Required for Maximal Leishmania Infection,” Molecular And Cellular Biology, vol. 32, no. 15, pp. 3176–3186, 2012. View at Publisher · View at Google Scholar
  • Wendy Macias Konstantopoulos, Michele Burns Ewald, and Daniel S. Pratt, “Case 22-2012: A 34-Year-Old Man with Intractable Vomiting after Ingestion of an Unknown Substance Antimony poisoning due to ingestion of tartar emetic (antimony potassium tartrate),” New England Journal Of Medicine, vol. 367, no. 3, pp. 259–268, 2012. View at Publisher · View at Google Scholar
  • Kifayatullah Shah, Muhammad Farid Khan, Amir Badshah, Haroon Khan, and Asim Urrehman, “Potassium antimony tartrate affects the chemical and metabolic status of glutathione in human blood: Ex vivo studies,” African Journal Of Pharmacy And Pharmacology, vol. 6, no. 5, pp. 310–316, 2012. View at Publisher · View at Google Scholar
  • J. Calla-Magariños, T. Quispe, A. Giménez, J. Freysdottir, M. Troye-Blomberg, and C. Fernández, “ Quinolinic Alkaloids from G alipea longiflora Krause Suppress Production of Proinflammatory Cytokines in vitro and Control Inflammation in vivo upon Leishmania Infection in Mice ,” Scandinavian Journal of Immunology, vol. 77, no. 1, pp. 30–38, 2012. View at Publisher · View at Google Scholar
  • Anette Stauch, Hans-Peter Duerr, Jean-Claude Dujardin, Manu Vanaerschot, Shyam Sundar, and Martin Eichner, “Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India,” Plos Neglected Tropical Diseases, vol. 6, no. 12, 2012. View at Publisher · View at Google Scholar
  • F. Seby, C. Gleyzes, O. Grosso, B. Plau, and O. F. X. Donard, “Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime(A (R))) by HPLC-ICP-MS and DPP,” Analytical And Bioanalytical Chemistry, vol. 404, no. 10, pp. 2939–2948, 2012. View at Publisher · View at Google Scholar
  • Katayoun Bahrami, Pardis Nazari, Zargham Sepehrizadeh, Bizhan Zarea, and Ahmad Reza Shahverdi, “Microbial synthesis of antimony sulfide nanoparticles and their characterization,” Annals Of Microbiology, vol. 62, no. 4, pp. 1419–1425, 2012. View at Publisher · View at Google Scholar
  • Sandra M. Leal, Arnold R. Romero Bohorquez, Patricia Escobar Rivero, and Vladimir V. Kouznetsov, “In Vitro Activity Against Trypanosoma cruzi and Leishmania chagasi Parasites of 2,4-Diaryl 1,2,3,4-Tetrahydroquinoline Derivatives,” Letters In Drug Design & Discovery, vol. 9, no. 8, pp. 802–808, 2012. View at Publisher · View at Google Scholar
  • Weon-Gyu Kho, “Pharmacotherapy for imported parasitic diseases with drugs reserved by the government,” Journal Of The Korean Medical Association, vol. 55, no. 1, pp. 49–55, 2012. View at Publisher · View at Google Scholar
  • Bahman Pourabbas, Abdolkarim Ghadimi Moghadam, Gholamreza Pouladfar, Zahra Rezaee, and Abdolvahab Alborzi, “Quantification of Leishmania infantum Kinetoplast DNA for Monitoring the Response to Meglumine Antimoniate Therapy in Visceral Leishmaniasis,” American Journal Of Tropical Medicine And Hygiene, vol. 88, no. 5, pp. 868–871, 2013. View at Publisher · View at Google Scholar
  • M. -A. Hartley, K. Kohl, C. Ronet, and N. Fasel, “The therapeutic potential of immune cross-talk in leishmaniasis,” Clinical Microbiology and Infection, vol. 19, no. 2, pp. 119–130, 2013. View at Publisher · View at Google Scholar
  • Sanchita Das, Priyanka Shah, Rajendra K. Baharia, Rati Tandon, Prashant Khare, Shyam Sundar, Amogh A. Sahasrabuddhe, M. I. Siddiqi, and Anuradha Dube, “Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani,” Plos Neglected Tropical Diseases, vol. 7, no. 12, 2013. View at Publisher · View at Google Scholar
  • Michael A. Collier, Matthew D. Gallovic, Kevin J. Peine, Anthony D. Duong, Eric M. Bachelder, John S. Gunn, Larry S. Schlesinger, and Kristy M. Ainslie, “Delivery of host cell-directed therapeutics for intracellular pathogen clearance,” Expert Review of Anti-Infective Therapy, vol. 11, no. 11, pp. 1225–1235, 2013. View at Publisher · View at Google Scholar
  • Manu Vanaerschot, Saskia Decuypere, Maya Berg, Syamal Roy, and Jean-Claude Dujardin, “Drug-resistant microorganisms with a higher fitness – can medicines boost pathogens?,” Critical Reviews in Microbiology, vol. 39, no. 4, pp. 384–394, 2013. View at Publisher · View at Google Scholar
  • Ajit K. Thakur, Sanjiva Bimal, Subhankar K. Singh, Anil K. Gupta, V. N. R. Das, Pradeep Das, and Shyam Narayan, “Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis,” Experimental Parasitology, vol. 135, no. 3, pp. 595–598, 2013. View at Publisher · View at Google Scholar
  • Franck Peysselon, Guillaume Launay, Frédérique Lisacek, Bertrand Duclos, and Sylvie Ricard-Blum, “Comparative analysis of Leishmania exoproteomes: implication for host-pathogens interactions,” Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013. View at Publisher · View at Google Scholar
  • Shalini Asthana, Pramod K Gupta, Mohini Chaurasia, Anuradha Dube, and Manish K Chourasia, “Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos,” Expert Opinion on Drug Delivery, pp. 1–19, 2013. View at Publisher · View at Google Scholar
  • Sarfaraz Ahmad Ejazi, and Nahid Ali, “Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects,” Expert Review Of Anti-Infective Therapy, vol. 11, no. 1, pp. 79–98, 2013. View at Publisher · View at Google Scholar
  • Mohammed Mumtaz Naiyer, Shipra Saha, Vijayshree Hemke, Somenath Roy, Shailza Singh, Krishnasastry V. Musti, and Bhaskar Saha, “Identification and characterization of a human IL-10 receptor antagonist,” Human Immunology, vol. 74, no. 1, pp. 28–31, 2013. View at Publisher · View at Google Scholar
  • Philip C. Andrews, Peter C. Junk, Lukasz Kedzierski, and Roshani M. Peiris, “Anti-Leishmanial Activity of Novel Homo- and Heteroleptic Bismuth(III) Thiocarboxylates,” Australian Journal of Chemistry, vol. 66, no. 10, pp. 1297–1305, 2013. View at Publisher · View at Google Scholar
  • Diana Granados-Falla, Carlos Coy-Barrera, Luis Cuca, and Gabriela Delgado, “<i>Seco</i>-limonoid 11<i>α</i>,19<i>β</i>-dihydroxy-7-acetoxy-7- deoxoichangin promotes the resolution of <i>Leishmania panamensis</i> infection,” Advances in Bioscience and Biotechnology, vol. 04, no. 02, pp. 304–315, 2013. View at Publisher · View at Google Scholar
  • Stephanie D. Kruchten, Kristina M. Bacon, and Bruce Y. Lee, “The Impact of Human Immunodeficiency Virus (HIV) Co-Infection on the Economic Burden of Cutaneous Leishmaniasis (CL) in Brazil and Potential Value of New CL Drug Treatments,” American Journal of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 520–527, 2014. View at Publisher · View at Google Scholar
  • Ludymila Furtado Cantanhêde, Laís Pinheiro Almeida, Rossy-Eric Pereira Soares, Patrícia Valéria Gomes Castelo Branco, and Silma Regina Ferreira Pereira, “Soy isoflavones have antimutagenic activity on DNA damage induced by the antileishmanial Glucantime (meglumine antimoniate),” Drug and Chemical Toxicology, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Rebecca J. Faleiro, Rajiv Kumar, Louise M. Hafner, and Christian R. Engwerda, “Immune Regulation during Chronic Visceral Leishmaniasis,” Plos Neglected Tropical Diseases, vol. 8, no. 7, 2014. View at Publisher · View at Google Scholar
  • S Kansal, R Tandon, A Verma, P Misra, A K Choudhary, R Verma, P R P Verma, A Dube, and P R Mishra, “ Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against L eishmania in hamsters by inducing Th1-type immune responses ,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Yih Ching Ong, Victoria L. Blair, Lukasz Kedzierski, and Philip C. Andrews, “ Stability and toxicity of heteroleptic organometallic Bi( v ) complexes towards Leishmania major ,” Dalton Transactions, vol. 43, no. 34, pp. 12904, 2014. View at Publisher · View at Google Scholar
  • Miguel Angel Moreno, Ana Alonso, Pedro Jose Alcolea, Ariel Abramov, Mario García de Lacoba, Jan Abendroth, Sunny Zhang, Thomas Edwards, Don Lorimer, Peter John Myler, and Vicente Larraga, “Tyrosine aminotransferase from Leishmania infantum: A new drug target candidate,” International Journal for Parasitology: Drugs and Drug Resistance, 2014. View at Publisher · View at Google Scholar
  • Banafsheh Nikmehr, Habib Ghaznavi, Amir Rahbar, Samira Sadr, and Saeed Mehrzadi, “In vitro anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officinalis leaves,” Chinese Journal of Natural Medicines, vol. 12, no. 6, pp. 423–427, 2014. View at Publisher · View at Google Scholar
  • Deise Riba Coelho, Elaine Silva Miranda, Tatiana Dillenburg Saint'Pierre, and Francisco Jose Roma Paumgartten, “Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate,” Memorias Do Instituto Oswaldo Cruz, vol. 109, no. 4, pp. 420–427, 2014. View at Publisher · View at Google Scholar
  • Rati Tandon, Sharat Chandra, Rajendra Kumar Baharia, Sanchita Das, Pragya Misra, Awanish Kumar, Mohammad Imran Siddiqi, Shyam Sundar, and Anuradha Dube, “Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 6, pp. 2997–3007, 2014. View at Publisher · View at Google Scholar
  • Banafsheh Nikmehr, Habib Ghaznavi, Amir Rahbar, Samira Sadr, and Saeed Mehrzadi, “In vitro anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officinalis leaves,” Chinese Journal of Natural Medicines, vol. 12, no. 6, pp. 423–427, 2014. View at Publisher · View at Google Scholar
  • Manu Vanaerschot, Franck Dumetz, Syamal Roy, Alicia Ponte-Sucre, Jorge Arevalo, and Jean-Claude Dujardin, “Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?,” Expert Review of Anti-infective Therapy, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Olga Lucia Fernandez, Yira Diaz-Toro, Clemencia Ovalle, Liliana Valderrama, Sandra Muvdi, Isabel Rodriguez, Maria Adelaida Gomez, and Nancy Gore Saravia, “Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia,” Plos Neglected Tropical Diseases, vol. 8, no. 5, 2014. View at Publisher · View at Google Scholar
  • Riccardo Rubbiani, Bettina Wahrig, and Ingo Ott, “Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe,” JBIC Journal of Biological Inorganic Chemistry, 2014. View at Publisher · View at Google Scholar
  • Amrita Bhattacharjee, Saikat Majumder, Suchandra Bhattacharyya Majumdar, Soumitra Kumar Choudhuri, Syamal Roy, and Subrata Majumdar, “Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis,” International Journal of Antimicrobial Agents, 2014. View at Publisher · View at Google Scholar
  • Deise R. Coelho, Rosangela R. De-Carvalho, Rafael C.C. Rocha, Tatiana D. Saint’Pierre, and Francisco J.R. Paumgartten, “Effects of in utero and lactational exposure to SbV on rat neurobehavioral development and fertility,” Reproductive Toxicology, 2014. View at Publisher · View at Google Scholar
  • Diego M. Santos, Antonio L. O. A. Petersen, Fabiana S. Celes, Valeria M. Borges, Patricia S. T. Veras, and Camila I. de Oliveira, “Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis,” Plos Neglected Tropical Diseases, vol. 8, no. 10, 2014. View at Publisher · View at Google Scholar
  • Sandip Mukherjee, Budhaditya Mukherjee, Rupkatha Mukhopadhyay, Kshudiram Naskar, Shyam Sundar, Jean-Claude Dujardin, and Syamal Roy, “Imipramine Exploits Histone Deacetylase 11 To Increase the IL-12/IL-10 Ratio in Macrophages Infected with Antimony-Resistant Leishmania donovani and Clears Organ Parasites in Experimental Infection,” Journal of Immunology, vol. 193, no. 8, pp. 4083–4094, 2014. View at Publisher · View at Google Scholar
  • Sarita Mohapatra, “Drug resistance in leishmaniasis: Newer developments.,” Tropical parasitology, vol. 4, no. 1, pp. 4–9, 2014. View at Publisher · View at Google Scholar
  • Andrew A. Voak, Karin Seifert, and Nuala A. Helsby, “Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal Prodrugs,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 1, pp. 370–377, 2014. View at Publisher · View at Google Scholar
  • Manu Vanaerschot, Silvie Huijben, Frederik Van den Broeck, and Jean-Claude Dujardin, “Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race,” Fems Microbiology Reviews, vol. 38, no. 1, pp. 41–55, 2014. View at Publisher · View at Google Scholar
  • Velusamy Gomathi Sankareswari, Devaraj Vinod, Ayyasamy Mahalakshmi, Meena Alamelu, Ganesan Kumaresan, Ramasamy Ramaraj, and Seenivasan Rajagopal, “Interaction of oxovanadium(iv)–salphen complexes with bovine serum albumin and their cytotoxicity against cancer,” Dalton Transactions, vol. 43, no. 8, pp. 3260, 2014. View at Publisher · View at Google Scholar
  • Philip C. Andrews, Victoria L. Blair, Richard L. Ferrero, Peter C. Junk, Lukasz Kedzierski, and Roshani M. Peiris, “Bismuth(III) beta-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents,” Dalton Transactions, vol. 43, no. 3, pp. 1279–1291, 2014. View at Publisher · View at Google Scholar
  • Shyam Sundar, Anup Singh, and Om Prakash Singh, “Strategies to Overcome Antileishmanial Drugs Unresponsiveness,” Journal of Tropical Medicine, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Silvio César Gomes de Lima, Maria Jania Teixeira, José Evaldo Gonçalves Lopes Júnior, Selene Maia de Morais, Alba Fabiola Torres, Milena Aguiar Braga, Raphael Oliveira Rodrigues, Gilvandete Maria Pinheiro Santiago, Alice Costa Martins, and Aparecida Tiemi Nagao-Dias, “In Vitro and In Vivo Leishmanicidal Activity of Astronium fraxinifolium (Schott) and Plectranthus amboinicus (Lour.) Spreng against Leishmania (Viannia) braziliensis,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Mansi Garg, and Neena Goyal, “MAPK1 of Leishmania donovani Modulates Antimony Susceptibility by Downregulating P-Glycoprotein Efflux Pumps,” Antimicrobial Agents And Chemotherapy, vol. 59, no. 7, pp. 3853–3863, 2015. View at Publisher · View at Google Scholar
  • Thais G. Passalacqua, Fabio A.E. Torres, Camila T. Nogueira, Leticia de Almeida, Mayara L. Del Cistia, Mariana B. dos Santos, Luis O. Regasini, Marcia A.S. Graminha, Reinaldo Marchetto, and Aderson Zottis, “The 2́,4́-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species,” Bioorganic & Medicinal Chemistry Letters, 2015. View at Publisher · View at Google Scholar
  • Rajalakshmi Rajasekaran, and Yi-Ping Phoebe Chen, “Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs,” Drug Discovery Today, 2015. View at Publisher · View at Google Scholar
  • Mabrook A Bin Mohanna, “Leishmaniasis, malaria, and schistosomiasis concurrently in an 8-year-old boy.,” Saudi medical journal, vol. 36, no. 4, pp. 494–6, 2015. View at Publisher · View at Google Scholar
  • Rubens Monte-Neto, Marie-Claude N. Laffitte, Philippe Leprohon, Priscila Reis, Frederic Frezard, and Marc Ouellette, “Intrachromosomal Amplification, Locus Deletion and Point Mutation in the Aquaglyceroporin AQP1 Gene in Antimony Resistant Leishmania (Viannia) guyanen,” Plos Neglected Tropical Diseases, vol. 9, no. 2, 2015. View at Publisher · View at Google Scholar
  • Goutam Mandal, Srotoswati Mandal, Mansi Sharma, Karen Santos Charret, Barbara Papadopoulou, Hiranmoy Bhattacharjee, and Rita Mukhopadhyay, “Species-Specific Antimonial Sensitivity in Leishmania Is Driven by Post-Transcriptional Regulation of AQP1,” Plos Neglected Tropical Diseases, vol. 9, no. 2, 2015. View at Publisher · View at Google Scholar
  • Seiichi Matsugo, Kan Kanamori, Hironori Sugiyama, Hirofumi Misu, and Toshinari Takamura, “Physiological roles of peroxido-vanadium complexes: Leitmotif as their signal transduction pathway,” Journal of Inorganic Biochemistry, 2015. View at Publisher · View at Google Scholar
  • P. Chellan, and P. J. Sadler, “The elements of life and medicines,” Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol. 373, no. 2037, pp. 20140182–20140182, 2015. View at Publisher · View at Google Scholar
  • Elisangela Oliveira Freitas, Dirlei Nico, Marcus Vinicius Alves-Silva, Alexandre Morrot, Keith Clinch, Gary B. Evans, Peter C. Tyler, Vern L. Schramm, and Clarisa B. Palatnik-de-Sousa, “Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis,” Plos Neglected Tropical Diseases, vol. 9, no. 12, 2015. View at Publisher · View at Google Scholar
  • Piyali Ganguli, Saikat Chowdhury, Shomeek Chowdhury, and Ram Rup Sarkar, “Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach,” EURASIP Journal on Bioinformatics and Systems Biology, vol. 2015, no. 1, 2015. View at Publisher · View at Google Scholar
  • Radhika Mathur, Rajeev Patrick Das, Archana Ranjan, and Chandrima Shaha, “Elevated ergosterol protects Leishmania parasites against antimony-generated stress,” Faseb Journal, vol. 29, no. 10, pp. 4201–4213, 2015. View at Publisher · View at Google Scholar
  • Miguel A Vasquez, Eva Iniguez, Umashankar Das, Stephen M Beverley, Linda J Herrera, Jonathan R Dimmock, and Rosa A Maldonado, “Evaluation of α,β-unsaturated ketones as antileishmanial agents.,” Antimicrobial agents and chemotherapy, vol. 59, no. 6, pp. 3598–601, 2015. View at Publisher · View at Google Scholar
  • Vineetha Mandlik, and Shailza Singh, “Molecular docking and molecular dynamics simulation study of inositol phosphorylceramide synthase – inhibitor complex in leishmaniasis: Insight into the structure based drug design,” F1000Research, vol. 5, pp. 1610, 2016. View at Publisher · View at Google Scholar
  • A. Rodrigues, M. Claro, G. Alexandre-Pires, D. Santos-Mateus, C. Martins, A. Valério-Bolas, M. Rafael-Fernandes, M.A. Pereira, I. Pereira da Fonseca, A.M. Tomás, and G. Santos-Gomes, “Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte,” Immunobiology, 2016. View at Publisher · View at Google Scholar
  • Vineetha Mandlik, and Shailza Singh, “Molecular docking and molecular dynamics simulation study of inositol phosphorylceramide synthase – inhibitor complex in leishmaniasis: Insight into the structure based drug design,” F1000Research, vol. 5, pp. 1610, 2016. View at Publisher · View at Google Scholar
  • Douglas R. Rice, Paola Vacchina, Brianna Norris-Mullins, Miguel A. Morales, and Bradley D. Smith, “Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major,” Antimicrobial Agents And Chemotherapy, vol. 60, no. 5, pp. 2932–2940, 2016. View at Publisher · View at Google Scholar
  • Nourridine Siewe, Abdul-Aziz Yakubu, Abhay R Satoskar, and Avner Friedman, “Immune Response to Infection by Leishmania: A Mathematical Model,” Mathematical Biosciences, 2016. View at Publisher · View at Google Scholar
  • Aya Hefnawy, Maya Berg, Jean-Claude Dujardin, and Géraldine De Muylder, “Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs,” Trends in Parasitology, 2016. View at Publisher · View at Google Scholar
  • Fabiana S. Celes, Eliane Trovatti, Ricardo Khouri, Johan Van Weyenbergh, Sidney J. L. Ribeiro, Valeria M. Borges, Hernane S. Barud, and Camila I. de Oliveira, “DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis,” Scientific Reports, vol. 6, pp. 38330, 2016. View at Publisher · View at Google Scholar
  • Y. Taslimi, F. Zahedifard, and S. Rafati, “Leishmaniasis and various immunotherapeutic approaches,” Parasitology, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Joachim Kloehn, Eleanor C. Saunders, and Malcolm J. McConville, “Using Metabolomic Approaches to Characterize the Human Pathogen Leishmania in Macrophages,” Microbial Metabolomics, pp. 83–117, 2016. View at Publisher · View at Google Scholar
  • Géraldine De Muylder, Benoit Vanhollebeke, Guy Caljon, Alan R. Wolfe, James McKerrow, and Jean-Claude Dujardin, “Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions,” PLOS Neglected Tropical Diseases, vol. 10, no. 12, pp. e0005234, 2016. View at Publisher · View at Google Scholar
  • Hendrickx, Pj Guerin, Caljon, Sl Croft, and Maes, “Evaluating drug resistance in visceral leishmaniasis: the challenges,” Parasitology, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Nourridine Siewe, Abdul-Aziz Yakubu, Abhay R Satoskar, and Avner Friedman, “Granuloma Formation in Leishmaniasis: A Mathematical Model,” Journal of Theoretical Biology, 2016. View at Publisher · View at Google Scholar
  • L. Maes, J. Beyers, A. Mondelaers, M. Van den Kerkhof, E. Eberhardt, G. Caljon, and S. Hendrickx, “ In vitro ‘time-to-kill’ assay to assess the cidal activity dynamics of current reference drugs against Leishmania donovani and Leishmania infantum : Table 1. ,” Journal of Antimicrobial Chemotherapy, pp. dkw409, 2016. View at Publisher · View at Google Scholar
  • Rajan Kumar Pandey, Parmila Verma, Drista Sharma, Tarun Kumar Bhatt, Shyam Sundar, and Vijay Kumar Prajapati, “High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania,” Biomedicine & Pharmacotherapy, vol. 83, pp. 141–152, 2016. View at Publisher · View at Google Scholar
  • Éverton da Silva Santos, Francielle Pelegrin Garcia, Priscila Miyuki Outuki, Jaqueline Hoscheid, Paulo Roberto Nunes de Goes, Lúcio Cardozo-Filho, Celso Vataru Nakamura, and Mara Lane Carvalho Cardoso, “Optimization of extraction method and evaluation of antileishmanial activity of oil and nanoemulsions of Pterodon pubescens benth. Fruit extracts,” Experimental Parasitology, 2016. View at Publisher · View at Google Scholar
  • Janine Krüger, Ernst Wellnhofer, Heike Meyborg, Philipp Stawowy, Arne Östman, Ulrich Kintscher, and Kai Kappert, “Inhibition of Src homology 2 domain-containing phosphatase 1 increases insulin sensitivity in high-fat diet-induced insulin-resistant mice,” FEBS Open Bio, vol. 6, no. 3, pp. 179–189, 2016. View at Publisher · View at Google Scholar
  • Daniel Boakye, Dziedzom de Souza, and Moses Bockarie, “Alternative Interventions Against Neglected Tropical Diseases in SSA: Vector Control,” Neglected Tropical Diseases - Sub-Saharan Africa, pp. 367–384, 2016. View at Publisher · View at Google Scholar
  • Graça Soveral, Søren Nielsen, Angela Casini, Angela Casini, and Andreia de Almeida, “Inorganic Compounds as Aquaporin Substrates or as Potent Inhibitors: A Coordination Chemistry Point of View,” Aquaporins in Health and Disease, pp. 297–318, 2016. View at Publisher · View at Google Scholar
  • Vineetha Mandlik, Sohan Patil, Ramanamurthy Bopanna, Sudipta Basu, and Shailza Singh, “Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents.,” PloS one, vol. 11, no. 10, 2016. View at Publisher · View at Google Scholar
  • Marcelo Verdugo, Yasumitsu Ogra, and Waldo Quiroz, “Mechanisms underlying the toxic effects of antimony species in human embryonic kidney cells (HEK-293) and their comparison with arsenic species,” The Journal of Toxicological Sciences, vol. 41, no. 6, pp. 783–792, 2016. View at Publisher · View at Google Scholar
  • M. R. Dikhit, A. Amit, A. K. Singh, A. Kumar, R. Mansuri, S. Sinha, R. K. Topno, R. Mishra, V. N. R. Das, K. Pandey, G. C. Sahoo, V. Ali, S. Bimal, and P. Das, “ Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC) ,” Parasite Immunology, pp. e12451, 2017. View at Publisher · View at Google Scholar
  • Edmond Differding, “The Drug Discovery and Development Industry in India-Two Decades of Proprietary Small-Molecule R&D,” ChemMedChem, 2017. View at Publisher · View at Google Scholar
  • Bilal Zulfiqar, Todd B. Shelper, and Vicky M. Avery, “Leishmaniasis drug discovery: recent progress and challenges in assay development,” Drug Discovery Today, 2017. View at Publisher · View at Google Scholar
  • Débora Cristina de Oliveira Nunes, Luiz Borges Bispo-da-Silva, Danielle Reis Napolitano, Mônica Soares Costa, Márcia Moura Nunes Rocha Figueira, Renata Santos Rodrigues, Veridiana de Melo Rodrigues, and Kelly Aparecida Geraldo Yoneyama, “In vitro additive interaction between ketoconazole and antimony against intramacrophage Leishmania (Leishmania) amazonensis amastigotes,” Plos One, vol. 12, no. 6, pp. e0180530, 2017. View at Publisher · View at Google Scholar
  • Vanessa Ribeiro Moreira, Luís Cláudio Lima de Jesus, Rossy-Eric Pereira Soares, Luis Douglas Miranda Silva, Bruno Araújo Serra Pinto, Maria Norma Melo, Antonio Marcus de Andrade Paes, and Silma Regina Ferreira Pereira, “Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.,” Antimicrobial agents and chemotherapy, vol. 61, no. 6, 2017. View at Publisher · View at Google Scholar
  • James C. Dabrowiak, “Metal Complexes for Killing Parasites, Bacteria and Viruses,” Metals in Medicine, pp. 285–327, 2017. View at Publisher · View at Google Scholar
  • Durdana Waseem, Arshad Farooq Butt, Ihsan-ul Haq, Moazzam Hussain Bhatti, and Gul Majid Khan, “Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents,” DARU Journal of Pharmaceutical Sciences, vol. 25, no. 1, 2017. View at Publisher · View at Google Scholar
  • Margot Wenzel, and Angela Casini, ““Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: current frontiers and perspectives“,” Coordination Chemistry Reviews, 2017. View at Publisher · View at Google Scholar
  • Maisa S. Fonseca, Marcelo A. Comini, Bethânia V. Resende, Ana Maria M. Santi, Antônio P. Zoboli, Douglas S. Moreira, and Silvane M.F. Murta, “Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony,” Experimental Parasitology, 2017. View at Publisher · View at Google Scholar
  • A. Rodrigues, D. Santos-Mateus, G. Alexandre-Pires, A. Valério-Bolas, M. Rafael-Fernandes, M.A. Pereira, D. Ligeiro, J. de Jesus, R. Alves-Azevedo, S. Lopes-Ventura, M. Santos, A.M. Tomás, I. Pereira da Fonseca, and G. Santos-Gomes, “Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 55, pp. 42–52, 2017. View at Publisher · View at Google Scholar
  • Rajiv Kumar, Shashi Bhushan Chauhan, Susanna S. Ng, Shyam Sundar, and Christian R. Engwerda, “Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Lauve Tchokouaha Yamthe, Regina Appiah-Opong, Patrick Tsouh Fokou, Nole Tsabang, Fabrice Fekam Boyom, Alexander Nyarko, and Michael Wilson, “Marine Algae as Source of Novel Antileishmanial Drugs: A Review,” Marine Drugs, vol. 15, no. 11, pp. 323, 2017. View at Publisher · View at Google Scholar
  • Raafat El-Awady, Ekram Saleh, Amna Hashim, Nehal Soliman, Alaa Dallah, Azza Elrasheed, and Ghada Elakraa, “The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy,” Frontiers in Pharmacology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Masoud Foroutan-Rad, Khosrow Hazrati Tappeh, and Shahram Khademvatan, “ Antileishmanial and Immunomodulatory Activity of Allium sativum (Garlic) ,” Journal of Evidence-Based Complementary & Alternative Medicine, vol. 22, no. 1, pp. 141–155, 2017. View at Publisher · View at Google Scholar
  • Masoud Doroodgar, Moein Doroodgar, and Abbas Doroodgar, “Unusual Presentation of Cutaneous Leishmaniasis: Ocular Leishmaniasis,” Case Reports in Infectious Diseases, vol. 2017, pp. 1–4, 2017. View at Publisher · View at Google Scholar
  • Luiz Filipe Gonçalves Oliveira, Franklin Souza-Silva, Léa Cysne-Finkelstein, Kíssila Rabelo, Juliana Fernandes Amorim, Adriana de Souza Azevedo, Saulo Cabral Bourguignon, Vitor Francisco Ferreira, Marciano Viana Paes, and Carlos Roberto Alves, “Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate,” BioMed Research International, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Khawaja Shakeel Ahmed, Nuredin Mohamedkassm Siraj, Henok Fitsumberhan, Sara Isaac, Semhar Yohannes, Dawit Eman, Yacob Berhane, and Matiwos Araya, “Knowledge, Attitude and Practice (KAP) Assessment of Intestinal Parasitic Infection among School Children in Asmara, Eritrea,” Health, vol. 09, no. 01, pp. 57–68, 2017. View at Publisher · View at Google Scholar
  • Swati Pund, and Amita Joshi, “Nanoarchitectures for Neglected Tropical Protozoal Diseases: Challenges and State of the Art,” Nano- and Microscale Drug Delivery Systems, pp. 439–480, 2017. View at Publisher · View at Google Scholar
  • Azar Shokri, Mahdi Abastabar, Masoud Keighobadi, Saeed Emami, Mahdi Fakhar, Saeed Hosseini Teshnizi, Koichi Makimura, Ali Rezaei-Matehkolaei, and Hassan Mirzaei, “Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies,” Journal of Global Antimicrobial Resistance, vol. 14, pp. 260–265, 2018. View at Publisher · View at Google Scholar
  • Mehmet Kürşat Derici, Demet Cansaran-Duman, and Ayşegül Taylan-Özkan, “Usnic acid causes apoptotic-like death in Leishmania major, L. infantum and L. tropica,” 3 Biotech, vol. 8, no. 9, 2018. View at Publisher · View at Google Scholar
  • Swati Kapil, Pankaj Kumar Singh, and Om Silakari, “An update on small molecule strategies targeting leishmaniasis,” European Journal of Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • Luís Cláudio Lima de Jesus, Rossy-Eric Pereira Soares, Vanessa Ribeiro Moreira, Raissa Lacerda Pontes, Patrícia Valéria Castelo-Branco, and Silma Regina Ferreira Pereira, “Genistein and Ascorbic Acid Reduce Oxidative Stress-Derived DNA Damage Induced by the Antileishmanial Meglumine Antimoniate,” Antimicrobial Agents and Chemotherapy, vol. 62, no. 9, 2018. View at Publisher · View at Google Scholar
  • Ejaz Hussain, Rajesh Kumar, M. Iqbal Choudhary, and Sammer Yousuf, “Crystal Engineering of Naturally Occurring Seselin To Obtain Cocrystal with Enhanced Anti-Leishmanial Activity, Hirshfeld Surface Analysis, and Computational Insight,” Crystal Growth & Design, 2018. View at Publisher · View at Google Scholar
  • Andrea Ilari, Ilaria Genovese, Fabiana Fiorillo, Theo Battista, Ilenia De Ionna, Annarita Fiorillo, and Gianni Colotti, “Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors,” Molecular Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Camila C. B. Brito, Fernando V. Maluf, Gustavo M. A. de Lima, Rafael V. C. Guido, and Marcelo S. Castilho, “Molecular Cloning and Biochemical Characterization of Iron Superoxide Dismutase from Leishmania braziliensis,” Molecular Biotechnology, 2018. View at Publisher · View at Google Scholar
  • Luiz Oliveira, Franklin Souza-Silva, Luzia de Castro Côrtes, Lea Cysne-Finkelstein, Mirian de Souza Pereira, Francisco de Oliveira Junior, Rosa Pinho, Suzana Corte Real, Saulo Bourguignon, Vitor Ferreira, and Carlos Alves, “Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2′-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment,” Molecules, vol. 23, no. 4, pp. 864, 2018. View at Publisher · View at Google Scholar
  • Tatjana Souza Lima Keesen, Larisse Virgolino da Silva, Juliana da Câmara Rocha, Luciana Nalone Andrade, Tamires Cardoso Lima, and Damião Pergentino de Sousa, “ Anti- Leishmania and cytotoxic activities of perillaldehyde epoxide synthetic positional isomers ,” Natural Product Research, pp. 1–5, 2018. View at Publisher · View at Google Scholar
  • Laiba Saleem, Ataf Ali Altaf, Amin Badshah, Muhammad Khawar Rauf, Amir Waseem, Muhammad Danish, Syed Sikander Azam, Muhammad Nadeem Arshad, Abdullah M. Asiria, Sajjad Ahmad, and Rukhsana Gul, “Structural Investigations, Anti-Leishmanial, Antibacterial and Docking Studies Of New Pentavalent Antimony Carboxylates,” Inorganica Chimica Acta, 2018. View at Publisher · View at Google Scholar
  • Jeronimo N. Rugani, Patrícia F. Quaresma, Célia F. Gontijo, Rodrigo P. Soares, and Rubens L. Monte-Neto, “Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions,” Biomedicine & Pharmacotherapy, vol. 108, pp. 1170–1180, 2018. View at Publisher · View at Google Scholar
  • Karin Luize Mazur, Paulo Emílio Feuser, Alexsandra Valério, Arthur Poester Cordeiro, Camila Indiani de Oliveira, João Paulo Assolini, Wander Rogério Pavanelli, Claudia Sayer, and Pedro H.H. Araújo, “Diethyldithiocarbamate loaded in beeswax-copaiba oil nanoparticles obtained by solventless double emulsion technique promote promastigote death in vitro,” Colloids and Surfaces B: Biointerfaces, 2018. View at Publisher · View at Google Scholar
  • Camila C. Bitencourt Brito, Hélder Vinicius Carneiro da Silva, Daci José Brondani, Antonio Rodolfo de Faria, Rafael Matos Ximenes, Ivanildo Mangueira da Silva, Julianna F. C. de Albuquerque, and Marcelo Santos Castilho, “ Synthesis and biological evaluation of thiazole derivatives as Lb SOD inhibitors ,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 34, no. 1, pp. 333–342, 2018. View at Publisher · View at Google Scholar
  • Adilson D. da Silva, Juliana A. dos Santos, Patrícia A. Machado, Lara A. Alves, Larissa C. Laque, Vinícius C. de Souza, Elaine S. Coimbra, and Priscila V. S. Z. Capriles, “ Insights about resveratrol analogs against trypanothione reductase of Leishmania braziliensis : Molecular modeling, computational docking and in vitro antileishmanial studies ,” Journal of Biomolecular Structure and Dynamics, pp. 1–10, 2018. View at Publisher · View at Google Scholar
  • Yih Ching Ong, Saonli Roy, Philip C. Andrews, and Gilles Gasser, “Metal Compounds against Neglected Tropical Diseases,” Chemical Reviews, 2018. View at Publisher · View at Google Scholar
  • Sara Abdolmaleki, Nasrin Yarmohammadi, Hadi Adibi, Mohammad Ghadermazi, Morahem Ashengroph, Hadi Amiri Rudbari, and Giuseppe Bruno, “Synthesis, X-ray studies, electrochemical properties, evaluation as in vitro cytotoxic and antibacterial agents of two antimony‌(III) complexes with dipicolinic acid,” Polyhedron, 2018. View at Publisher · View at Google Scholar
  • Luiza F. O. Gervazoni, Gabriella Gonçalves-Ozório, and Elmo E. Almeida-Amaral, “2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis,” PLOS Neglected Tropical Diseases, vol. 12, no. 12, pp. e0006930, 2018. View at Publisher · View at Google Scholar
  • Paulo Emilio Feuser, Maiko Luis Tonini, Amanda Virtuoso Jacques, Maria Claudia Santos da Silva, Mario Steindel, Claudia Sayer, and Pedro Henrique Hermes de Araújo, “ Increased in vitro leishmanicidal activity of octyl gallate loaded poly(methyl methacrylate) nanoparticles ,” Pharmaceutical Development and Technology, vol. 24, no. 5, pp. 593–599, 2018. View at Publisher · View at Google Scholar
  • Ganesh Yadagiri, and Prati Pal Singh, “Chemotherapy and Experimental Models of Visceral Leishmaniasis,” Infectious Diseases and Your Health, pp. 63–97, 2018. View at Publisher · View at Google Scholar
  • Ariane Sousa-Batista, and Bartira Rossi-Bergmann, “Nanomedicines for Cutaneous Leishmaniasis,” Leishmaniases as Re-emerging Diseases, 2018. View at Publisher · View at Google Scholar
  • Wim Adriaensen, Thomas P. C. Dorlo, Guido Vanham, Luc Kestens, Paul M. Kaye, and Johan van Griensven, “Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients,” Frontiers in Immunology, vol. 8, 2018. View at Publisher · View at Google Scholar
  • Maximilian Obinna Obiakor, Matthew Tighe, Lily Pereg, and Susan C. Wilson, “Bioaccumulation, trophodynamics and ecotoxicity of antimony in environmental freshwater food webs,” Critical Reviews in Environmental Science and Technology, pp. 1–51, 2018. View at Publisher · View at Google Scholar
  • Chiara Borsari, Antonio Quotadamo, Stefania Ferrari, Alberto Venturelli, Anabela Cordeiro-da-Silva, Nuno Santarem, and Maria Paola Costi, “Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis,” 2018. View at Publisher · View at Google Scholar
  • C. Benjamin Naman, Ciro M. Gomes, and Gaurav Gupta, “Phytodrugs and Immunomodulators for the Therapy of Leishmaniasis,” Natural Products and Drug Discovery, pp. 213–275, 2018. View at Publisher · View at Google Scholar
  • Tamara C. M. Lopes, Débora F. Silva, Walyson C. Costa, Frédéric Frézard, José M. Barichello, Neila M. Silva-Barcellos, Wanderson G. de Lima, and Simone A. Rezende, “Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice Liver,” Pathology Research International, vol. 2018, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Pijush Kanti Pramanik, Md Nur Alam, Dibyapriya Roy Chowdhury, and Tapati Chakraborti, “Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival,” Journal of Global Antimicrobial Resistance, vol. 18, pp. 1–11, 2019. View at Publisher · View at Google Scholar
  • Yadan Zhou, Wei Feng, Xiaoqin Qian, Luodan Yu, Xiuguo Han, Gonglin Fan, Yu Chen, and Jiang Zhu, “Construction of 2D Antimony(III) Selenide Nanosheets for Highly Efficient Photonic Cancer Theranostics,” ACS Applied Materials & Interfaces, vol. 11, no. 22, pp. 19712–19723, 2019. View at Publisher · View at Google Scholar
  • Mojtaba Salimi, Abedin Saghafipour, Hadi Hamidi Parsa, Majid Khosravi, and Mohammad Reza Shirzadi, “Economic Burden Evaluation of Cutaneous Leishmaniasis in Iran,” Shiraz E-Medical Journal, vol. 20, no. 6, 2019. View at Publisher · View at Google Scholar
  • Mônica Soares Costa, Yasmim Garcia Gonçalves, Samuel Cota Teixeira, Débora Cristina de Oliveira Nunes, Daiana Silva Lopes, Claudio Vieira da Silva, Marcelo Santos da Silva, Bruna Cristina Borges, Marcelo José Barbosa Silva, Renata Santos Rodrigues, Veridiana de Melo Rodrigues, Gustavo Von Poelhsitz, and Kelly Aparecida Geraldo Yoneyama, “Increased ROS generation causes apoptosis-like death: Mechanistic insights into the anti-Leishmania activity of a potent ruthenium(II) complex,” Journal of Inorganic Biochemistry, 2019. View at Publisher · View at Google Scholar
  • Mallikarjuna Rao Gedda, Om Prakash Singh, Onkar Nath Srivastava, and Shyam Sundar, “Therapeutic Leishmaniasis: Recent Advancement and Developments in Nanomedicines,” Nanotechnology in Modern Animal Biotechnology, pp. 195–220, 2019. View at Publisher · View at Google Scholar
  • Beatriz Mendes Santos, Adriana Bezerra-Souza, Sonia Aragaki, Eliana Rodrigues, Eric Umehara, João Henrique Ghilardi Lago, Márcia Dalastra Laurenti, Susan Pereira Ribeiro, and Luiz Felipe Domingues Passero, “Ethnopharmacology Study of Plants from Atlantic Forest with Leishmanicidal Activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, pp. 1–8, 2019. View at Publisher · View at Google Scholar
  • Hui Ling Chia, Naziah Mohamad Latiff, Rui Gusmão, Zdeněk Sofer, and Martin Pumera, “Cytotoxicity of Shear Exfoliated Pnictogen (As, Sb, Bi) Nanosheets,” Chemistry - A European Journal, 2019. View at Publisher · View at Google Scholar
  • Patrícia de Almeida Machado, Monique Pacheco Duarte Carneiro, Ariane de Jesus Sousa Batista, Francisco Jose Pereira Lopes, Ana Paula Cabral de Araújo Lima, Suzana Passos Chaves, Ana Carolina Rennó Sodero, and Herbert Leonel de Matos Guedes, “Leishmanicidal therapy targeted to parasite proteases,” Life Sciences, 2019. View at Publisher · View at Google Scholar
  • Ariane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho, Fagner Santos do Carmo, Marta de Souza Albernaz, and Ralph Santos-Oliveira, “Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis,” American Journal of Therapeutics, vol. 26, no. 1, pp. e12–e17, 2019. View at Publisher · View at Google Scholar
  • Neeraj Tiwari, Arun Kumar, Ashish K. Singh, Surabhi Bajpai, Anand K. Agrahari, Dhiraj Kishore, Vinod K. Tiwari, and Rakesh K. Singh, “Leishmaniasis control: limitations of current drugs and prospects of natural products,” Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases, pp. 293–350, 2019. View at Publisher · View at Google Scholar